Amyloid PET studies have shown asymmetric amyloid deposition in preclinical Alzheimer’s disease, which becomes more symmetric with cognitive decline,46 while asymmetric tau patterns have also been described in tau PET studies as well including a left-sided predominant subtype in 19% of patients with Alzheimer’s disease.47 The gene discussed is MAPT; the disease is Alzheimer disease.